🇺🇸 FDA
Patent

US 11225469

Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof

granted A61KA61K45/06A61P

Quick answer

US patent 11225469 (Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K45/06, A61P, A61P35/00, A61P43/00